ABOUT THIS EVENT

Lyra Therapeutics, Inc. (Nasdaq: LYRA), a recent IPO company that had its first day of trading on May 1, 2020, and is focused on solutions for ear, nose and throat (ENT) diseases, rang the Nasdaq Opening Bell remotely.

Lyra is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. 

In honor of the occasion, Maria Palasis, CEO of Lyra Therapeutics, rang the Opening Bell alongside board members, executives, and employees in a virtual bell ringing ceremony.